A high content screen dissecting ciliogenesis and oncogenic Hedgehog signaling
A high content screen dissecting ciliogenesis and oncogenic Hedgehog signaling
批准号:
9107196
负责人:
Michelle Arkin
金额:
$36.26万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-03-23 至 2019-02-28
关键词:
AllelesAllosteric SiteBasal Cell Nevus SyndromeBasal cell carcinomaBehaviorBindingBiological AssayBiological ProcessBiologyCancer EtiologyCell Cycle ProgressionCell MaintenanceCellsChemicalsChildhood Solid NeoplasmCiliaCilium MicrotubuleClinicalCombination Drug TherapyComplexCritical PathwaysDevelopmentDiseaseDissectionDistalEmbryonic DevelopmentErinaceidaeFamilial diseaseGeneticGenetic TranscriptionGrowthHousingHumanIntegral Membrane ProteinInvestigationLeadLearningLibrariesLigandsMalignant Childhood NeoplasmMalignant Epithelial CellMalignant NeoplasmsMammalian CellMicrotubulesMolecularMovementMutationNatural ProductsOncogenicOrganellesPathway interactionsPatternPharmaceutical PreparationsPredispositionProcessProteinsReagentRelapseResistanceSignal TransductionSignaling ProteinSiteSolidStem cellsSurfaceTestingTissuesTranslationsUnited StatesUnited States National Institutes of HealthVertebratesVesnarinoneappendagebasecell growthcilium biogenesiscombatcounterscreencyclopaminedrug developmentfightinghedgehog signal transductioninhibitor/antagonistinsightkinetosomeloss of functionmedulloblastomanovelpreventpublic health relevanceresponsesmall molecule inhibitorsmall molecule librariessmoothened signaling pathwaytooltraffickingtranscription factortumortumorigenesis
中文摘要
描述(由申请人提供):这项提案寻求识别和表征抑制睫状体Hedgehog(HH)信号的类药物分子。细胞通过HH蛋白等分泌信号进行交流,从而协调自己的行为。与其他细胞间信号不同,哺乳动物的HH蛋白是通过初级纤毛传递的,初级纤毛是许多细胞表面基于微管的投射。赖特实验室发现,HH途径的中心成分Smoothens(Smo)在HH刺激下移动到初级纤毛,在那里它激活下游途径。纤毛在胚胎发育和肿瘤发生中对HH信号是必不可少的。Smo的激活突变会导致基底细胞癌(BCC)和髓母细胞瘤,前者是美国最常见的癌症,后者是儿童最常见的实体癌症。一种Smo拮抗剂最近被批准用于临床,尽管癌症可能很快就会产生耐药性。通过互补机制发挥作用的SMO拮抗剂可能会防止HH相关癌症中出现耐药性。为了确定新的HH途径拮抗剂并深入了解纤毛功能,赖特和阿尔金实验室完成了一项针对Smo向纤毛运动的抑制剂的中试筛选。这一筛选确定了新的抑制剂,一些
其中一些通过抑制Smo转位来阻止BCC细胞的生长,有些还通过阻止纤毛的形成来阻止BCC细胞的生长。对这些抑制物作用机制的研究揭示了纤毛HH信号以前未知的方面。该项目将扩大筛选范围,确定抑制物作用的分子机制,并了解纤毛信号。具体地说,我们将:1)筛选内部和化学生物学联盟文库,大幅扩大已评估的化学空间;2)执行二次筛选,以有效地识别通过先前未描述的机制发挥作用的抑制剂;3)使用新发现的拮抗剂,结合独特的遗传工具,揭示纤毛发生和Smo易位的未知步骤。尽管它们对发育和疾病都很重要,但纤毛发生和HH信号转导的机制仍不清楚。这项拟议的研究将提供工具,以揭示细胞如何通过纤毛进行交流。这些化合物还可能为新的化疗药物提供线索,这些药物对于防止HH途径相关癌症出现耐药和复发至关重要。
英文摘要
DESCRIPTION (provided by applicant): This proposal seeks to identify and characterize drug-like molecules that inhibit ciliary Hedgehog (Hh) signaling. Cells orchestrate their behaviors by communicating through secreted signals such as Hh proteins. Unlike other intercellular signals, mammalian Hh proteins are transduced through primary cilia, microtubule-based projections on the surface of many cells. The Reiter lab discovered that a central component of the Hh pathway, Smoothened (Smo), moves to the primary cilium in response to Hh stimulation where it activates the downstream pathway. The cilium is essential for Hh signaling both in embryonic development and in oncogenesis. Activating mutations in Smo cause basal cell carcinoma (BCC), the most common cancer in the U.S., and medulloblastoma, the most common solid cancer in children. A Smo antagonist was recently approved for clinical use, although cancers can become resistant quickly. Smo antagonists that act through complementary mechanisms may prevent the emergence of resistance in Hh-associated cancers. To identify novel Hh pathway antagonists and gain insight into ciliary function, the Reiter and Arkin labs completed a pilot screen for inhibitors of Smo movement to cilia. This screen identified novel inhibitors, some
of which block BCC cell growth by inhibiting Smo translocation and some of which block ciliogenesis. Investigating the mechanisms by which these inhibitors act revealed previously unknown aspects of ciliary Hh signaling. This project will expand the screen, identify the molecular mechanisms underlying inhibitor action, and understand ciliary signaling. Specifically, we will: 1) screen in-house and Chemical Biology Consortium libraries, substantially expanding the chemical space that has been assessed, 2) execute secondary screens to efficiently identify inhibitors that act through previously undescribed mechanisms, 3) use newly identified antagonists, together with unique genetic tools, to uncover unrecognized steps of ciliogenesis and Smo translocation. Despite their importance to both development and disease, the mechanisms underlying ciliogenesis and Hh signaling remain unclear. The proposed investigation will provide tools to reveal how cells communicate through cilia. These compounds may also provide leads for novel chemotherapeutics, critical for preventing the emergence of resistance and relapse in Hh pathway-associated cancers.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of caspase-6 inhibitors for treatment of NASH
-
批准号:10608905
-
项目类别:
-
资助金额:$71.74万
-
财政年份:2023
-
负责人:Michelle Arkin
-
依托单位:
Optimizing brain penetrance of caspase-6 inhibitors to treat neurodegenerative diseases
-
批准号:10603619
-
项目类别:
-
资助金额:$18.04万
-
财政年份:2023
-
负责人:Michelle Arkin
-
依托单位:
Systematic stabilization of specific protein-protein interactions
-
批准号:10703416
-
项目类别:
-
资助金额:$31.67万
-
财政年份:2022
-
负责人:Michelle Arkin
-
依托单位:
Screening core
-
批准号:10512620
-
项目类别:
-
资助金额:$460.24万
-
财政年份:2022
-
负责人:Michelle Arkin
-
依托单位:
Systematic stabilization of specific protein-protein interactions
-
批准号:10502096
-
项目类别:
-
资助金额:$41.67万
-
财政年份:2022
-
负责人:Michelle Arkin
-
依托单位:
Bruker Sierra SPR-24 Pro
-
批准号:10175786
-
项目类别:
-
资助金额:$30.43万
-
财政年份:2021
-
负责人:Michelle Arkin
-
依托单位:
Discovery of Small Molecule Ligands for PHD1 Reader Domain of Histone Demethylase KDM5A
-
批准号:10183207
-
项目类别:
-
资助金额:$57.77万
-
财政年份:2020
-
负责人:Michelle Arkin
-
依托单位:
Discovery of Small Molecule Ligands for PHD1 Reader Domain of Histone Demethylase KDM5A
-
批准号:10650159
-
项目类别:
-
资助金额:$57.22万
-
财政年份:2020
-
负责人:Michelle Arkin
-
依托单位:
Discovery of Small Molecule Ligands for PHD1 Reader Domain of Histone Demethylase KDM5A
-
批准号:10442482
-
项目类别:
-
资助金额:$57.22万
-
财政年份:2020
-
负责人:Michelle Arkin
-
依托单位:
Protein and small-molecule tools to probe the conformational dependence of the VCP/p97 protein-protein interaction network
-
批准号:10228038
-
项目类别:
-
资助金额:$34.07万
-
财政年份:2018
-
负责人:Michelle Arkin
-
依托单位:
A high content screen dissecting ciliogenesis and oncogenic Hedgehog signaling
-
批准号:9248278
-
项目类别:
-
资助金额:$36.26万
-
财政年份:2016
-
负责人:Michelle Arkin
-
依托单位:
Screening for inhibitors of p300-mediated tau acetylation for Alzheimer's Disease
-
批准号:8878152
-
项目类别:
-
资助金额:$24.59万
-
财政年份:2014
-
负责人:Michelle Arkin
-
依托单位:
Translational Studies Linking Aging and Cancer
-
批准号:8867984
-
项目类别:
-
资助金额:$31.34万
-
财政年份:2013
-
负责人:Michelle Arkin
-
依托单位:
Exploring statins as a small molecule therapy for treatment of schistosomiasis
-
批准号:8670699
-
项目类别:
-
资助金额:$23.69万
-
财政年份:2013
-
负责人:Michelle Arkin
-
依托单位:
Translational Studies Linking Aging and Cancer
-
批准号:9307661
-
项目类别:
-
资助金额:$32.3万
-
财政年份:2013
-
负责人:Michelle Arkin
-
依托单位:
An automated high throughput phenotypic screen for schistosomiasis drug discovery
-
批准号:8259789
-
项目类别:
-
资助金额:$42.89万
-
财政年份:2010
-
负责人:Michelle Arkin
-
依托单位:
An automated high throughput phenotypic screen for schistosomiasis drug discovery
-
批准号:8072723
-
项目类别:
-
资助金额:$42.31万
-
财政年份:2010
-
负责人:Michelle Arkin
-
依托单位:
A novel high content screen for regulators of ciliogenesis and Hedgehog signaling
-
批准号:8050478
-
项目类别:
-
资助金额:$15.45万
-
财政年份:2010
-
负责人:Michelle Arkin
-
依托单位:
An automated high throughput phenotypic screen for schistosomiasis drug discovery
-
批准号:7947512
-
项目类别:
-
资助金额:$49.47万
-
财政年份:2010
-
负责人:Michelle Arkin
-
依托单位:
2008 Biomolecular Interactions and Methods Gordon Research Conference
-
批准号:7405811
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2008
-
负责人:Michelle Arkin
-
依托单位:
海外基金